Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
C
Caris Life Sciences Inc
NASDAQ:CAI
Caris Life Sciences Inc
NASDAQ:CAI
Price:
32.495
USD
-1.08%
Market Closed
Market Cap:
$9.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
US |
|
Seagate Technology Holdings PLC
NASDAQ:STX
|
IE |
|
N
|
Northrop Grumman Corp
DUS:NTH
|
US |
|
Xtra Gold Resources Corp
TSX:XTG
|
BS |
|
E
|
EQT Corp
XMUN:EQ6
|
US |
|
S
|
Salesforce Inc
DUS:FOO
|
US |
|
O
|
Omnicom Group Inc
XMUN:OCN
|
US |
Wall St Price Targets
CAI Price Forecast
Based on 14 analysts
Based on 14 analysts
-6% Downside
from
$32.495
today
Caris Life Sciences Inc (CAI)’s 12-month stock price forecast through November 2027 has a consensus target of $30.6, implying 6% downside. The forecast is based on price targets from 14 Wall Street analysts.
Caris Life Sciences Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CAI's stock price target?
Price Target
30.6
USD
30.6
USD
According to Wall Street analysts, the average 1-year price target for CAI is 30.6 USD with a low forecast of 22.22 USD and a high forecast of 37.8 USD.
What is the Revenue forecast for Caris Life Sciences Inc?
Projected CAGR
15%
15%
Over the last 1 year, the compound annual growth rate for Revenue has been 97%. The projected CAGR for the next 8 years is 15%.
What is the Gross Profit forecast for Caris Life Sciences Inc?
Projected CAGR
16%
16%
Over the last 1 year, the compound annual growth rate for Gross Profit has been 200%. The projected CAGR for the next 8 years is 16%.
What is the Operating Income forecast for Caris Life Sciences Inc?
Projected CAGR
39%
39%
The compound annual growth rate for Operating Income over the next 8 years is 39%.